<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="overview of migraine, including current therapeutics and the link to" exact="calcitonin" post="gene-related peptide (CGRP), a neuropeptide strongly implicated in migraine"/>
 <result pre="some drugs used only with migraine prevention objectives, such as" exact="flunarizine" post="and pizotifene [ 1]. Importantly, recent clinical evidence has"/>
 <result pre="used only with migraine prevention objectives, such as flunarizine and" exact="pizotifene" post="[ 1]. Importantly, recent clinical evidence has supported the"/>
 <result pre="involvement of neurogenic inflammation and, in particular, of the neuropeptide" exact="calcitonin" post="gene related peptide (CGRP) [ 12]. Neurogenic inflammation is"/>
 <result pre="Migraine CGRP, a neuropeptide produced from alternative splicing of the" exact="calcitonin" post="gene, acts as a relevant signaling peptide in mammalian"/>
 <result pre="CGRP acts via a G protein-coupled receptor constituted by the" exact="calcitonin" post="receptor-like receptor (CLR), the receptor activity-modifying protein 1 (RAMP1)"/>
 <result pre="vessels on the headache side during migraine attacks triggered by" exact="cilostazol" post="has recently been found, a finding that the authors"/>
 <result pre="are unclear, but preclinical studies using repeated 30-day administration of" exact="eletriptan" post="or indomethacin found increased TRPV1 (and TRPA1) in the"/>
 <result pre="but preclinical studies using repeated 30-day administration of eletriptan or" exact="indomethacin" post="found increased TRPV1 (and TRPA1) in the trigeminal ganglia,"/>
 <result pre="as an analgesic mechanism as is the case for topical" exact="menthol" post="[ 53]. Consistent with this idea is a recent"/>
 <result pre="such as hydrogen sulfide (H 2S) as well as to" exact="nitric oxide" post="(NO), both of which are well known to cause"/>
 <result pre="ganglion. Consistent with this study was another report showing that" exact="nitroglycerin" post="can increase hyperalgesia in the orofacial formalin test in"/>
 <result pre="this circuitry has also been emerging for other drugs. Both" exact="valproic acid" post="and topiramate have been shown to inhibit the capsaicin-induced"/>
 <result pre="also been emerging for other drugs. Both valproic acid and" exact="topiramate" post="have been shown to inhibit the capsaicin-induced elevation of"/>
 <result pre="adult and pediatric rats [ 136]. Finally, the pretreatment with" exact="valproic acid" post="has been shown to attenuate the enhanced blood flow"/>
 <result pre="A. Kane S.A. Tajti J. Edvinsson L. Differential distribution of" exact="calcitonin" post="gene-related peptide and its receptor components in the human"/>
 <result pre="Szolcsanyi J. Bagdy G. Sumatriptan causes parallel decrease in plasma" exact="calcitonin" post="gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin"/>
 <result pre="plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during" exact="nitroglycerin" post="induced migraine attack Cephalalgia 2005 25 179 183 10.1111/j.1468-2982.2005.00836.x"/>
 <result pre="Sperling B. Iversen H.K. Olesen J. Tfelt-Hansen P. Involvement of" exact="calcitonin" post="gene-related peptide in migraine: Regional cerebral blood flow and"/>
 <result pre="Zhang Z. Wemmie J.A. Anderson M.G. Russo A.F. Role of" exact="calcitonin" post="gene-related peptide in light-aversive behavior: Implications for migraine J."/>
 <result pre="and tolerability of MK-0974 (telcagepant), a new oral antagonist of" exact="calcitonin" post="gene-related peptide receptor, compared with zolmitriptan for acute migraine:"/>
 <result pre="new oral antagonist of calcitonin gene-related peptide receptor, compared with" exact="zolmitriptan" post="for acute migraine: A randomised, placebo-controlled, parallel-treatment trial Lancet"/>
 <result pre="et al. Safety and efficacy of ALD403, an antibody to" exact="calcitonin" post="gene-related peptide, for the prevention of frequent episodic migraine:"/>
 <result pre="D.S. Safety and efficacy of LY2951742, a monoclonal antibody to" exact="calcitonin" post="gene-related peptide, for the prevention of migraine: A phase"/>
 <result pre="843 854 10.1002/ejp.986 27977070 118. Olesen J. The role of" exact="nitric oxide" post="(NO) in migraine, tension-type headache and cluster headache Pharmacol."/>
 <result pre="Z. Zhu X. Li D. He H. The role of" exact="nitric oxide" post="in orofacial pain Nitric Oxide 2012 26 32 37"/>
 <result pre="V.P. Ferreira S.H. Pain and analgesia: The dual effect of" exact="nitric oxide" post="in the nociceptive system Nitric Oxide 2011 25 243"/>
 <result pre="I. Geisslinger G. No NO, no pain? The role of" exact="nitric oxide" post="and cGMP in spinal pain processing Trends Neurosci. 2009"/>
 <result pre="E. Cuzzocrea S. Salvemini D. Modulation of prostaglandin biosynthesis by" exact="nitric oxide" post="and nitric oxide donors Pharmacol. Rev. 2005 57 217"/>
 <result pre="Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and" exact="nitric oxide" post="donors Pharmacol. Rev. 2005 57 217 252 10.1124/pr.57.2.1 15914468"/>
 <result pre="M.E. Cady R. Durham P. An exploratory study of salivary" exact="calcitonin" post="gene-related peptide levels relative to acute interventions and preventative"/>
</results>
